Business context and reporting period
Mobix Labs, Inc. filed this Form 8-K on October 2, 2026, reporting results of its special stockholder meeting held that day. This is a corporate-governance filing, not a financial-results report.
Financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Meeting results and material changes
Holders representing 9,416,734 Class A shares, or approximately 52.45% of the voting power as of the September 8, 2026 record date, were represented at the meeting; a quorum was present. All four proposals were approved.
| Proposal | For | Against | Abstentions | Broker non-votes |
|---|---|---|---|---|
| Reverse Split Amendment | 7,680,758 | 1,719,286 | 16,690 | Not stated |
| 2023 Equity Incentive Plan Amendment | 2,747,842 | 1,475,554 | 70,445 | 5,122,893 |
| Kips Issuance | 3,636,132 | 626,788 | 30,921 | 5,122,893 |
| Leviston Issuance | 3,587,818 | 676,498 | 29,525 | 5,122,893 |
Outlook, risks, contingencies, and unusual items
The filing gives no financial guidance, management outlook, or discussion of risks or contingencies. It does not specify the reverse split ratio or timing, the details of the equity-plan amendment, or the terms and potential dilution associated with the Kips and Leviston issuances.
Key facts for investors to verify
- Review the September 14, 2026 proxy statement for the terms and intended implementation of all four approved proposals.
- Verify the reverse split ratio, effective date, and any resulting changes to shares outstanding.
- Verify the scope of the equity-plan amendment and the terms, recipients, and potential dilution from the Kips and Leviston issuances.